IDT Australia Limited (ASX:IDT)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Pharmaceuticals	19.77M	14.02M	6.99M	12.13M	16.93M
Pharmaceuticals Growth	40.99%	100.67%	-42.41%	-28.34%	19.46%
Total	19.77M	14.02M	6.99M	12.13M	16.93M
Total Growth	40.99%	100.67%	-42.41%	-28.34%	19.46%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Australia	15.29M	9.82M	5.33M	12.13M	16.93M
Australia Growth	55.75%	84.13%	-56.04%	-28.34%	19.46%
Asia	119.00K	158.00K	-	-	-
Asia Growth	-24.68%	-	-	-	-
Europe	45.00K	630.00K	612.00K	-	-
Europe Growth	-92.86%	2.94%	-	-	-
USA	3.76M	2.62M	991.00K	-	-
USA Growth	43.55%	164.38%	-	-	-
Total	19.22M	13.23M	6.94M	12.13M	16.93M
Total Growth	45.30%	90.71%	-42.83%	-28.34%	19.46%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 17, 2026

Data Sources Report a data error